Literature DB >> 11382379

Expanding directly observed therapy: tuberculosis to human immunodeficiency virus.

D R Bangsberg, L M Mundy, J P Tulsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11382379     DOI： 10.1016/s0002-9343(01)00729-x

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  8 in total

1.  Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy.

Authors:  Jean B Nachega; Richard E Chaisson; Rene Goliath; Anne Efron; Mohammad A Chaudhary; Malathi Ram; Chelsea Morroni; Hennie Schoeman; Amy R Knowlton; Gary Maartens
Journal:  AIDS       Date:  2010-06-01       Impact factor: 4.177

Review 2.  Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.

Authors:  Jessica E Hart; Christie Y Jeon; Louise C Ivers; Heidi L Behforouz; Adolfo Caldas; Peter C Drobac; Sonya S Shin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-06       Impact factor: 3.731

3.  Sticking to it: the effect of maximally assisted therapy on antiretroviral treatment adherence among individuals living with HIV who are unstably housed.

Authors:  Surita Parashar; Alexis K Palmer; Nadia O'Brien; Keith Chan; Anya Shen; Suzy Coulter; Julio S G Montaner; Robert S Hogg
Journal:  AIDS Behav       Date:  2011-11

Review 4.  Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals.

Authors:  Gregory M Lucas
Journal:  Life Sci       Date:  2010-10-01       Impact factor: 5.037

5.  Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial.

Authors:  Frederick L Altice; Duncan Smith-Rohrberg Maru; R Douglas Bruce; Sandra A Springer; Gerald H Friedland
Journal:  Clin Infect Dis       Date:  2007-08-13       Impact factor: 9.079

6.  Cost of behavioral interventions utilizing electronic drug monitoring for antiretroviral therapy adherence.

Authors:  Rafia S Rasu; David F Malewski; Julie W Banderas; Domonique Malomo Thomson; Kathy Goggin
Journal:  J Acquir Immune Defic Syndr       Date:  2013-05-01       Impact factor: 3.731

7.  Study design and participant characteristics of a randomized controlled trial of directly administered antiretroviral therapy in opioid treatment programs.

Authors:  Bernadette Anna Mullen; Katie Cook; Richard D Moore; Cynthia Rand; Noya Galai; Mary E McCaul; Sheldon Glass; Krisann K Oursler; Gregory M Lucas
Journal:  BMC Infect Dis       Date:  2011-02-15       Impact factor: 3.090

Review 8.  Improving the Adherence to Antiretroviral Therapy, a Difficult but Essential Task for a Successful HIV Treatment-Clinical Points of View and Practical Considerations.

Authors:  Simona A Iacob; Diana G Iacob; Gheorghita Jugulete
Journal:  Front Pharmacol       Date:  2017-11-23       Impact factor: 5.810
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.